Fact CheckerSign in

NCT07630090Not yet recruitingPhase 4

Gastric Feeding for the Prevention of Stroke-Associated Pneumonia

Comparing Early Post-pyloric Feeding Versus Gastric Feeding for the Prevention of Stroke-Associated Pneumonia in Patients With Severe Ischemic Stroke

Source: ClinicalTrials.gov · Last updated 5 Jun 2026

Brief summary (registry, in English)

This randomized controlled trial aims to compare the effectiveness of early post-pyloric feeding versus gastric feeding in preventing SAP in patients with severe ischemic stroke. The main question to answer is whether post-pyloric feeding group is better than the gastric feeding group for preventing SAP.

Status (registry)
Not yet recruiting
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
174 (estimated)
First submitted
27 May 2026
Start date
15 Jun 2026
Primary completion date
16 Jun 2027
Lead sponsor
Jinling Hospital, China
Diseases
Stroke
NCT number
NCT07630090

What you commit to

  • Study type: Interventional · Phase 4
  • Planned participants: 174
  • From 15 Jun 2026 to the primary completion date, 16 Jun 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • High risk of gastrointestinal bleeding or perforation
  • Advanced malignant tumor

Other

  • Diagnosed with pneumonia upon admission
  • Intestinal obstruction or gastrointestinal obstruction
  • Severe liver or kidney dysfunction
  • Pregnancy or breastfeeding
  • Refusal to participate in the study

Who the study is looking for

  • Age ≥ 18 years
  • Diagnosis of severe ischemic stroke, with NIHSS score \> 16 \[15-16\]
  • Confirmed dysphagia via swallowing assessment (Kubota Water Swallowing Test ≥ grade 3, or confirmed aspiration risk by FEES/VFSS)
  • Time from onset to enrollment ≤ 72 hours
  • Expected survival ≥ 7 days
  • Non-mechanically ventilated patients
  • Signed informed consent from patient or legal representative.

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Jinling Hospital, Medical School of Nanjing University, Nanjing
Coordinator of this site? Confirm its status
NanjingChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.